SGC, HitGen collaborate on DEL technology for drug discovery
HitGen will leverage its DNA-encoded library (DEL) technology platform for the collaboration, specifically the OpenDEL solution, a self-service…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
29 Sep 23
HitGen will leverage its DNA-encoded library (DEL) technology platform for the collaboration, specifically the OpenDEL solution, a self-service…
29 Sep 23
The FDA has cleared the muscle disorder therapy only for adult LOPD patients whose weight is ≥40kg and…
29 Sep 23
Scynexis has recalled the drug over potential risk of cross contamination with a non-antibacterial ß-lactam drug substance in…
29 Sep 23
The drug’s mechanism of targeted single serotonin (5HT) 1a receptor agonism reduced depressive symptoms with an acceptable side…
29 Sep 23
Nestlé aims to grow the sales of its more nutritious products by CHF 20-25 billion by 2030. This represents about…
29 Sep 23
AI-driven literature extraction for thousands of rare disease genes fortifies and extends QIAGEN’s proprietary, human-certified content, providing complete…
29 Sep 23
Unlocking the AI Revolution - A Symposium on the future of the Healthcare Industry and Diagnostic Imaging in…
29 Sep 23
Interview with Anni Matthes and Dr. Robby Markwart, Research associates, Institute of General Practice and Family Medicine at…
29 Sep 23
Rockstar Debuts Limited-Edition Cans Inspired by the Vibrant Iconography of the Longstanding Mexican Holiday Featuring Rockstar Pure Zero,…
29 Sep 23
If approved, sotatercept would be the first in its class, bringing a novel approach to address a rare…